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the aggregation of α-synuclein (αS), a protein abundant at presynaptic terminals, is associated 
with a range of highly debilitating neurodegenerative conditions, including parkinson’s disease (pD), 
dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). emerging evidence indicates 
that the interaction of αS with lipid membranes defines both its physiological function and pathological 
effects. The characterisation of the modes of membrane binding by αS is therefore crucial to clarify 
the balance between normal and aberrant behaviour of this protein. Here we used solid-state nuclear 
magnetic resonance (ssnMR) spectroscopy to probe the nature of the n-terminally acetylated form 
of αS (ntAc-αS) bound to synaptic-like lipid vesicles. This post-translational modification is prevalent 
for the physiological form of αS and modulates the binding to lipid bilayers. By probing the structure, 
dynamics and membrane topology of ntAc-αS, we found that n-terminal acetylation does not alter 
significantly the conformational and topological properties of the membrane-bound state of αS, 
despite increasing its propensity for binding. taken together, our data and previous characterisations 
of the cytosolic state of ntAc-αS clarify that the role of the n-terminal acetylation is to regulate the 
binding affinity of αS for synaptic vesicles without altering the structural properties of the bound state.
α-Synuclein (αS) is a 14 kDa monomeric disordered protein preferentially found at pre-synaptic termini1. The 
aggregation of αS is strongly linked with Parkinson’s disease (PD)2–6, as its aggregates are the major constituents 
of Lewy bodies in PD patients7–9. Point mutations, as well as duplications and triplications, in the αS gene are also 
associated with familial forms of PD10–15, and fibrillar aggregates of the non-amyloid-β component (NAC) region 
of the protein (residues 61–95) are associated with Alzheimer’s disease16.
The function of αS is currently still debated. Several lines of evidence have indicated a possible role for this 
protein in the regulation of the trafficking of synaptic vesicles (SVs)17, including the maintenance of pools of SVs 
at the synaptic termini18–22, the promotion of interactions between SVs23–26 and the assistance of SNARE forma-
tion during neurotransmitter release27–30. αS has also been shown to bind mitochondrial membranes, where it 
may have role in the mitigation of oxidative stress of mitochondria31–33. A common characteristic of the majority 
of these putative functions is that they all require the binding of αS to lipid membranes34. Indeed, the partition 
between membrane-bound and cytosolic forms of αS is tightly regulated in vivo35 and appears to be crucial for the 
mechanism of αS aggregation21,36–41 as well as the toxicity of its fibrillar oligomers42. Understanding the biological 
regulation of this interaction is therefore a major priority to clarify the balance between functional and dysfunc-
tional aspects in this presynaptic protein.
Upon membrane binding αS undergoes a transition from an intrinsically disordered monomeric protein43–45 
to a conformation that is enriched in α-helical structure. This ordering process is promoted by 7 imperfect 
sequence repeats of 11 residues located in the first 90 residues of the protein sequence and encoding for amphi-
pathic α-helical motifs45. The modular organization of the repeats provides αS with the ability to bind a variety 
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of assemblies ranging from small detergent micelles to lipid vesicles and membranes43,46,47 using a multiplicity of 
distinct binding modes43.
Membrane binding by αS is modulated by some post-translational modifications (PTMs), including the phos-
phorylation of different residues in the sequence48–50. Moreover, the N-terminal acetylation of αS51,52, which is 
found in both healthy individuals and PD patients, has been shown to induce stronger membrane affinity, as well 
as an increased propensity to adopt transient α-helical structures in the N-terminal region53,54, a property that is 
enhanced upon copper interaction55,56.
As the N-terminally acetylated αS (NTAc-αS) is considered to be the physiologically relevant form, and 
because of the central role of membrane binding for both functional and pathological contexts, it is important to 
investigate how this PTM alters the structure and dynamics of the membrane bound state of αS. Although previ-
ous studies have analysed the interaction between NTAc-αS and lipid membranes by probing the properties of its 
unbound state50,53,54,57, a full understanding of the structural and dynamical properties of the membrane-bound 
state of NTAc-αS is currently missing.
To answer to this key question, we here employed solid-state NMR (ssNMR) to directly probe the conforma-
tional properties of NTAc-αS at the surface of small unilamellar vesicles (SUVs) that mimic synaptic vesicles for 
composition and size43,44. Using an approach based on paramagnetic relaxation enhancement (PRE) effects, we 
investigated the impact of the N-terminal acetylation on the topological properties of the protein with respect 
to the lipid membrane. Our experiments elucidated the nature of the membrane-bound state of NTAc-αS and 
clarified further the role of this PTM on the regulation of the membrane interaction of αS.
Results
ssnMR spectra of ntAc-αS bound to lipid vesicles. Previous magic angle spinning (MAS) ssNMR 
studies of non-acetylated αS identified three different regions of the protein having distinctive structural and 
dynamical properties in the membrane-bound state44. These regions include the N-terminal portion of the pro-
tein, which spans the initial 25 residues and acts as the primary membrane-binding motif that adopts the confor-
mation of a stable amphipathic helix anchoring the protein onto the membrane surface. It was possible to assign 
the ssNMR resonances of the segment 6–25 of this region44 and employ these data to refine its structural ensemble 
when bound to synaptic-like vesicles58. In addition to the rigid N-terminal anchor, a central ‘sensor’ region (res-
idues 26 to 98) resulted to have enhanced relaxation properties in the ssNMR spectra, suggesting that it exists in 
equilibrium between multiple conformations at the membrane surface (Fig. 1)44. The central region was shown 
to modulate the overall affinity of the protein for lipid bilayers44 as well as to be involved in the mechanism by 
which αS promotes the clustering of synaptic vesicles23. Finally, the C-terminal residues (99 to 140) were found 
to remain largely unstructured and unbound to lipid bilayers, with some residues establishing transient contacts 
with the membrane surface44.
We here used ssNMR to investigate the effects of N-terminal acetylation to the membrane-bound form of αS. 
13C-15N labelled NTAc-αS samples were mixed with DOPE:DOPS:DOPC (5:3:2 w/w) SUVs at a protein:lipid ratio 
of 1:6544 and pelleted via ultracentrifugation into 3.2 mm rotors for MAS ssNMR. 13C-13C dipolar assisted rota-
tional resonance (DARR)59 spectra of membrane-bound NTAc-αS, which were measured at −19 °C to enhance 
the signal to noise under conditions where this lipid mixture adopts a gel phase60, revealed a number of res-
onances belonging to residues from the N-terminal region in a rigid bound state at the surface of the SUVs 
(Fig. 2a). A close inspection of the resonances from these spectra revealed no significant differences between the 
chemical shifts of the membrane bound states of NTAc-αS and non-acetylated αS44. Similarly, by analysing the 
Figure 1. Representation of the SUV-bound state of αS. Schematic illustration of the binding mode of αS to a 
lipid vesicle. Three regions of protein have different dynamical and structural properties upon binding with the 
membrane44. The 25 N-terminal residues (blue) are rigidly anchored to the membrane surface, adopting a stable 
α-helical conformation. The central region, spanning residue 26–98 (red), is in equilibrium between bound-
tethered and unbound-detached conformations. The C-terminal region (residues 98–140, green) remains 
unstructured and weakly associated with the membrane surface.
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bound state of NTAc-αS with SUVs composed of POPG lipids, which induce stronger membrane binding by 
αS61, we obtained 13C-13C-DARR spectra that are essentially indistinguishable from those measured in the case 
of non-acetylated αS44 (Fig. 2b).
In addition to 13C-13C-DARR spectra probing rigid regions of the protein, we measured insensitive nuclei 
enhanced by polarization transfer (INEPT) spectra62 to characterise the highly dynamic protein regions of 
NTAc-αS bound to DOPE:DOPS:DOPC SUVs (Fig. 3). 13C detected 1H-13C correlations and 1H detected 1H-
15N correlations63 revealed a number of ssNMR resonances of residues in the disordered regions of the protein. 
The resulting chemical shifts closely match those measured in 1H-13C HSQC and 1H-15N HSQC spectra of the 
monomeric form of αS measured using solution NMR44. These spectra revealed the N-H and C-H cross peaks of 
Figure 2. MAS ssNMR spectra to detect rigid regions of NTAc-αS bound to SUVs. (a,b) 13C-13C DARR 
correlation spectra were measured for NTAc-αS bound to DOPE:DOPS:DOPC (a) and POPG (b) vesicles 
using 1 ms and 50 ms for contact and mixing times, respectively. The spectra were recorded at −19 °C to favour 
the gel phase of the lipid membrane and obtain enhanced signal to noise measurements. The experiments 
were performed at a 1H Larmor frequency of 700 MHz using a 3.2 mm EFree probe and a spinning rate of 
10.0 kHz. Cross correlations between aliphatic-aliphatic and aliphatic-carbonyl regions are shown, with residue 
names reported with the single letter convention. Assignments of the spectra were derived from previous 
studies of vesicle bound αS44. Atom names ca, cb, cg, cd are used for Cα, Cβ, Cγ and Cδ atoms, respectively. c) 
Population of α-helix (residue specific percentage of secondary structure SS%) derived by using the chemical 
shifts from the ssNMR spectra as input for the δ2D program77. Non-acetylated and acetylated αS bound to 
DOPE:DOPS:DOPC vesicles are shown in yellow and orange, respectively.
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residues spanning the region 97 to 140 of the protein, and showed no considerable differences with the chemical 
shifts measured using both monomeric-disordered αS in water and non-acetylated αS at the surface of SUVs.
Taken together, ssNMR experiments indicated that the dynamical and structural properties of both rigid 
and disordered regions of αS bound to the surface of lipid bilayers do not change significantly as a result of the 
N-terminal acetylation.
Membrane insertion of the n-terminal anchor of ntAc-αS. Next, we used ssNMR to directly 
probe the topological properties of the membrane-bound state of NTAc-αS. In particular, using paramagnetic 
relaxation enhancement (PRE)64,65 experiments, we could obtain detailed information of the levels of protein 
insertion into the hydrophobic region of the lipid bilayer. These experiments were performed by doping the 
DOPE:DOPS:DOPC lipid mixture with low quantities (2%) of lipids that incorporate a paramagnetic centre into 
their chemical structure. The spatial vicinity of protein regions to this centre enhances the transverse relaxation of 
their NMR signals, thereby providing a map of the contacts between the protein and the spin. Four different types 
of paramagnetic lipids were used to obtain a map of the contacts between the protein and spins placed at differ-
ent positions of the membrane, i.e. from the hydrophilic head groups to the last carbon of the hydrophobic tail 
(Fig. 4). PRE measured via 13C-13C-DARR spectra by doping the membrane with a paramagnetic centre in head 
groups (gadolinium salt of PE-DTPA, Avanti Polar Lipids, USA) provided evidence of contacts between atoms of 
the N-terminal region of NTAc-αS and the membrane surface. The spectra showed selective paramagnetic broad-
ening of 13C-13C DARR resonances for both aliphatic-aliphatic and aliphatic-carbonyl cross-peaks, and suggested 
the topology of an amphipathic helix laying parallel on the membrane surface (Fig. 4). We then probed the degree 
of insertion of the N-terminal region of NTAc-αS into the hydrophobic region of the membrane by measuring 
PREs with paramagnetic lipids having spins at the positions of carbons 5, 10 and 16 of the lipid tail. These PRE 
experiments showed a gradual reduction of the paramagnetic broadening effect when changing the position of 
the spin from carbon 5 to carbon 16 of the lipid tail (Fig. 4), with the latter showing no evidence of PRE effect in 
the DARR spectrum.
These data indicate mild levels of insertion of the N-terminal region of NTAc-αS into the lipid bilayer, a result 
that is consistent with PRE experiments previously performed under the same experimental conditions by using 
non-acetylated αS44,58.
Discussion
Although close links between PD and the aggregation of αS are widely recognised, the physiological role of this 
presynaptic protein remains largely unclear17. It has now become evident that a fundamental element for the bio-
logical activity of αS is the interaction with lipid membranes66, which appears to be crucial in defining the balance 
between normal and aberrant forms of this protein. The membrane-binding affinity by αS is primarily influenced 
by the properties of the lipid bilayer, including curvature, charge, packing defects and surface hydrophobic-
ity46,47,67–69, but other factors such as calcium binding70, phosphorylation48–50 and N-terminal acetylation51,52 have 
also been shown to modulate this interaction.
Figure 3. INEPT-based identification of dynamical regions of NTAc-αS bound to DOPE:DOPS:DOPC 
SUVs. 13C-detected 1H-13C correlation via INEPT transfer (a) and 1H-detected 1H-15N-HSQC (b) of NTAc-αS 
bound to DOPE:DOPS:DOPC SUVs recorded at 4 °C using MAS ssNMR with spinning rate of 10 kHz. The 
experiments were performed at a 1H Larmor frequency of 700 MHz using a 3.2 mm EFree probe. Atom names 
ca, cb, cg, cd are used for Cα, Cβ, Cγ and Cδ atoms, respectively. Assignment of the spectra were derived from 
previous studies of vesicle bound αS44.
5Scientific RepoRtS |          (2020) 10:204  | https://doi.org/10.1038/s41598-019-57023-4
www.nature.com/scientificreportswww.nature.com/scientificreports/
We have used here ssNMR spectroscopy to investigate the structure, dynamics and membrane-topology of 
NTAc-αS bound to synaptic-like vesicles. The acetylation of the N-terminal residue of αS is indeed prevalent in 
both healthy individuals and PD patients51–56, and characterising its influence on the modes of membrane binding 
is crucial to understand biological behaviour of this protein. Previous solution NMR studies have probed this 
interaction by studying the properties of the unbound state of NTAc-αS in equilibrium with its membrane-bound 
form53,54. The resulting spectra showed increased relaxation properties for the resonances of the N-terminal 
region of the protein indicating stronger membrane-binding for this region when the protein is acetylated. This 
result is consistent with the present chemical exchange saturation transfer (CEST) experiments that enabled to 
characterise the equilibrium between bound and unbound states at a residue-specific level (Fig. 5). CEST meas-
urements also showed no significant decrease in the saturation of residues that immediately follow the N-terminal 
region, as observed in the non-acetylated case44, indicating stronger membrane affinity for these residues in the 
case of NTAc-αS.
Despite these observations of higher membrane affinity in NTAc-αS, our ssNMR spectra indicate that this 
PTM does not alter the conformational properties of the membrane-bound state of the protein. In particular, 
cross polarisation and INEPT spectra, probing respectively rigid and highly dynamical regions of the protein 
(Figs. 2 and 3), indicated no substantial differences in the structure and dynamics of the membrane-bound states 
of NTAc-αS compared to non-acetylated αS44. The analysis of the chemical shifts of the bound states of NTAc-αS 
and non-acetylated αS showed a similar content of α-helix in the N-terminal region (Fig. 2c), indicating a single 
binding mode for this protein segment in both protein constructs. Moreover ssNMR PRE experiments, provided 
evidence that the modes of membrane insertion of the N-terminal anchor of αS are not significantly altered by 
the N-terminal acetylation.
Figure 4. Membrane insertion properties of the N-terminal region of NTAc-αS using PREs. ssNMR PRE of 
membrane bound NTAc-αS were measured by doping to DOPE:DOPS:DOPC SUVs with 2% of lipid molecules 
having a paramagnetic centre in different positions ranging from the hydrophilic head group (1-palmitoyl-
2-stearoyl-[5-doxyl]-sn-glycero-3-phosphocholine) to the position of carbons 5, 10 and 16 of the lipid tail 
(1-palmitoyl-2-stearoyl-[N-doxyl]-sn-glycero-3-phosphocholine, N = 5, 10, 16). The chemical structures of 
the paramagnetically labelled lipids are shown in the corresponding spectra. 13C-13C-DARR spectra of these 
samples were measured at −19 °C to favour the gel phase of the membrane44, and using 1 ms and 50 ms for 
contact and mixing times, respectively. The experiments were performed at a 1H Larmor frequency of 700 MHz 
using a 3.2 mm EFree probe and a MAS rate of 10.0 kHz. Spectra in the presence and absence of the paramagnetic 
lipids are shown in green and red, respectively.
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Taken together, these data indicate that the enhanced affinity of NTAc-αS for binding biological membranes 
is not the result of any specific alteration of its membrane-bound state, and suggest that it is likely promoted by 
changes in the properties of the unbound αS, particularly the increased α-helical character in the N-terminal 
region53. The presence of transient α-helical conformations in the N-terminal region of the unbound NTAc-αS 
has the likely effect of relieving part of the entropic cost associated with the disorder-to-order transition required 
for the membrane binding. This intrinsic α-helical propensity may also favour the reversibility of the membrane 
interaction, which is essential to promote a rapid equilibrium between bound and unbound states, a key element 
for the ability of αS to facilitate the interaction between synaptic vesicles23–26. This biological property has been 
associated with the putative function of αS of regulating distal pools of synaptic vesicles that play a key role for the 
SV homeostasis during neurotransmitter release20–22.
In conclusion the topological and structural properties of the membrane-bound state of NTAc-αS that we 
have described here contribute to the definition of the mechanism by which the N-terminal acetylation regulates 
the mechanism of binding to synaptic membranes.
Methods
ntAc-αS purification. αS was expressed and purified as previously described44. Briefly the protein was 
expressed in E. coli using plasmid pT7–744. In order to obtain N-terminal acetylation of αS we used coexpression 
with a plasmid carrying the components of the NatB complex (Addgene).
After transforming in BL21 (DE3)-gold cells (Agilent Technologies, Santa Clara, USA), uniformly 15N and/or 
13C labeled αS variants were obtained by growing the bacteria in isotope-enriched M9 minimal media containing 
1 g.L−1 of 15N ammonium chloride, 2 g.L−1 of 13C-glucose (Sigma-Aldrich, St Louis, USA) and 1 g of protonated 
Figure 5. CEST experiments probing the binding equilibrium of NTAc-αS. CEST 1H-15N HSQC spectra were 
recorded by applying a continuous wave saturation (170 Hz or 350 Hz) on the 15N resonance with offsets ranging 
from −28 kHz to + 28 kHz, and using a reference spectrum measured with an offset of 100 kHz. Measurements 
were carried out using a protein concentration of 300 μM and 0.06% (0.6 mg/ml) of SUVs composed of 
DOPE:DOPS:DOPC lipids in a ratio of 5:3:2 (w/w). (a,b) CEST surfaces measured using bandwidths of 350 Hz 
and 170 Hz, respectively. (c,d) CEST saturation along the αS sequence measured using bandwidths of 350 Hz 
and 170 Hz, respectively. Black, red and green lines refer to the averaged CEST profiles measured using offsets 
at + /− 1.5 kHz, + /− 3 kHz and + /− 5 kHz, respectively.
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IsoGro 15N-13C (Sigma, St. Louis, MO). The growth was obtained at 37 °C under constant shaking at 250 rpm and 
supplemented with 100 μg.ml−1 ampicillin to an OD600 of 0.6. The expression was induced with 1 mM isopropyl 
β-D-1-thiogalactopyranoside (IPTG) at 37 °C for 4 h, and the cells were harvested by centrifugation at 6200 g 
(Beckman Coulter, Brea, USA). The cell pellets were resuspended in lysis buffer (10 mM Tris-HCl pH 8, 1 mM 
EDTA and EDTA-free complete protease inhibitor cocktail tablets obtained from Roche, Basel, Switzerland) 
and lysed by sonication. The cell lysate was centrifuged at 22,000 g for 30 min to remove cell debris. In order to 
precipitate the heat-sensitive proteins, the supernatant was then heated for 20 min at 70 °C and centrifuged at 
22,000 g. Subsequently streptomycin sulfate was added to the supernatant to a final concentration of 10 mg.ml−1 
to stimulate DNA precipitation. The mixture was stirred for 15 min at 4 °C followed by centrifugation at 22,000 g. 
Then, ammonium sulfate was added to the supernatant to a concentration of 360 mg.ml−1 in order to precipitate 
the protein. The solution was stirred for 30 min at 4 °C and centrifuged again at 22,000 g. The resulting pellet 
was resuspended in 25 mM Tris-HCl, pH 7.7 and dialyzed against the same buffer in order to remove salts. The 
dialyzed solutions were then loaded onto an anion exchange column (26/10 Q sepharose high performance, GE 
Healthcare, Little Chalfont, UK) and eluted with a 0–1 M NaCl step gradient, and then further purified by loading 
onto a size exclusion column (Hiload 26/60 Superdex 75 preparation grade, GE Healthcare, Little Chalfont, UK). 
All the fractions containing the monomeric protein were pooled together and concentrated by using Vivaspin 
filter devices (Sartorius Stedim Biotech, Gottingen, Germany). The purity of the aliquots after each step was 
analyzed by SDS-PAGE and the protein concentration was determined from the absorbance at 275 nm using 
an extinction coefficient of 5600 M−1 cm−1. Mass spectrometry was used to assess that the level of N-terminal 
acetylation was complete.
preparation of SUVs. Small unilamellar vesicles (SUVs) containing DOPE:DOPS:DOPC at a ratio of 
5:3:2 (w/w) or POPG (Avanti Polar Lipids Inc., Alabaster, USA) were prepared from chloroform solutions of 
the lipids as described previously43,44. Briefly, the lipid mixture was evaporated under a stream of nitrogen gas 
and then dried thoroughly under vacuum to yield a thin lipid film. The dried thin film was then re-hydrated by 
adding aqueous buffer (20 mM sodium phosphate, pH 6.0) at a concentration of 15 mg.ml−1 (1.5%) and subjected 
to vortex mixing. In all NMR experiments described in this paper SUVs were obtained by using several cycles of 
freeze-thawing and sonication until the mixture became clear43,44. For ssNMR studies αS was added to the SUV 
mixtures up to a molar ratio of 1:65 protein:lipid. The mixtures were then pelleted at 303,747 g for 30 min at 4 °C 
(Beckman Coulter Optima TLX Inc. Brea, USA) by using a TLA 100.3 rotor. Subsequently the SUV-αS samples 
were transferred into 3.2 mm Zirconia XC thin-walled MAS rotors for ssNMR experiments.
Magic angle spinning (MAS) measurements. MAS ssNMR measurements were used to directly probe 
the resonances of NTAc-αS in the vesicle-bound state, which are inaccessible to solution-state NMR. MAS exper-
iments were carried out on a 700 MHz Bruker Spectrometer with a 3.2 mm EFree probe. Dipolar assisted rotational 
resonance (DARR) experiments59 were performed at a MAS rate of 10 kHz using a mixing time of 50 ms and a 
contact time of 1 ms. DARR spectra were acquired at −19 °C to favour signal to noise by inducing a gel phase of 
the lipid membranes. Previous studies showed that the chemical shifts of αS bound to DOPE:DOPS:DOPC SUVs 
at −19 °C and 4 °C are indistinguishable, ruling out conformational changes of the protein as a result of the differ-
ent phases of the lipids44. Insensitive nuclei enhanced by polarization transfer (INEPT) spectra62 were measured at 
4 °C using a MAS rate of 10 kHz. Pulse widths were 2.5 μs for 1H and 5.5 μs for 13C, and 1H TPPM decoupling was 
applied at ωRF/(2π) = 71.4–100 kHz44. 1H detected 1H-15N-HSQC of membrane bound NTAc-αS was measured 
as in Gopinath et al.63. Assignments of the resonances of NTAc-αS in DARR and INEPT spectra were derived 
from our previous study of αS bound to SUVs or unbound αS44.
chemical exchange saturation transfer (ceSt) experiments. CEST measurements44,71–75 probed the 
equilibrium between membrane unbound and membrane bound states of αS via direct detection of saturation in 
the resonances of the unbound state. In studying αS-SUV interactions, CEST shows higher sensitivity than meas-
urements based on the signal attenuation in HSQC spectra, which enables measurements at low lipid:protein ratios 
to minimise αS or lipid aggregation44. Moreover, CEST signals are directly sensitive to the interaction between αS 
and the membrane surface and minimise the interference from additional factors that can contribute to the trans-
verse relaxation rates of the protein resonances72–75. Solution state NMR experiments were carried out at 10 °C on 
a sample composed of αS (300 μM) incubated with DOPE:DOPS:DOPC SUVs at a concentration of 0.6 mg/ml 
and using a Bruker spectrometer operating at 1H frequencies of 700 MHz equipped with triple resonance HCN 
cryo-probe. CEST experiments were based on 1H-15N HSQC spectra by applying constant wave saturation in the 
15N channel. Assignment of the solution NMR resonances was obtained from our previous studies44 and controlled 
with a series of 3D spectra by following a published protocol76. Since we aimed at probing the exchange between 
monomeric αS (having sharp resonances) and αS bound to SUVs (having significantly broader resonances), a 
series of large offsets was employed (−28, −21, −14, −9, −5, −3, −1.5, 0, 1.5, 3, 5, 9, 14, 21 and 28 kHz), resulting 
in CEST profiles of symmetrical shapes44,72,73. An additional spectrum, saturated at −100 kHz, was recorded as 
a reference. The CEST experiments were measured using a data matrix consisting of 2048 (t2, 1H) × 220 (t1, 15N) 
complex points.
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